Noncoding RNA therapeutics—challenges and potential solutions

M Winkle, SM El-Daly, M Fabbri, GA Calin - Nature reviews Drug …, 2021 - nature.com
Therapeutic targeting of noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and
long noncoding RNAs (lncRNAs), represents an attractive approach for the treatment of …

Targeted protein degradation: A promise for undruggable proteins

KTG Samarasinghe, CM Crews - Cell chemical biology, 2021 - cell.com
Summary Protein homeostasis, or" proteostasis," is indispensable for a balanced, healthy
environment within the cell. However, when natural proteostasis mechanisms are …

Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs

SB Alabi, CM Crews - Journal of Biological Chemistry, 2021 - ASBMB
Of late, targeted protein degradation (TPD) has surfaced as a novel and innovative chemical
tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates …

Reimagining druggability using chemoproteomic platforms

JN Spradlin, E Zhang, DK Nomura - Accounts of Chemical …, 2021 - ACS Publications
Conspectus One of the biggest bottlenecks in modern drug discovery efforts is in tackling the
undruggable proteome. Currently, over 85% of the proteome is still considered undruggable …

Reprogramming of protein-targeted small-molecule medicines to RNA by ribonuclease recruitment

P Zhang, X Liu, D Abegg, T Tanaka… - Journal of the …, 2021 - ACS Publications
Reprogramming known medicines for a novel target with activity and selectivity over the
canonical target is challenging. By studying the binding interactions between RNA folds and …

Single-cell microRNA sequencing method comparison and application to cell lines and circulating lung tumor cells

SM Hücker, T Fehlmann, C Werno, K Weidele… - Nature …, 2021 - nature.com
Molecular single cell analyses provide insights into physiological and pathological
processes. Here, in a stepwise approach, we first evaluate 19 protocols for single cell small …

Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G4C2) repeat expansion in vitro and in vivo ALS models

JA Bush, H Aikawa, R Fuerst, Y Li, A Ursu… - Science translational …, 2021 - science.org
The most common cause of amyotrophic lateral sclerosis and frontotemporal dementia
(c9ALS/FTD) is an expanded G4C2 RNA repeat [r (G4C2) exp] in chromosome 9 open …

A map of the SARS-CoV-2 RNA structurome

RJ Andrews, CA O'Leary, VS Tompkins… - NAR genomics and …, 2021 - academic.oup.com
SARS-CoV-2 has exploded throughout the human population. To facilitate efforts to gain
insights into SARS-CoV-2 biology and to target the virus therapeutically, it is essential to …

miRNAs and lncRNAs as novel therapeutic targets to improve cancer immunotherapy

MT Di Martino, C Riillo, F Scionti, K Grillone, N Polerà… - Cancers, 2021 - mdpi.com
Simple Summary Cancer onset and progression are promoted by high deregulation of the
immune system. Recently, major advances in molecular and clinical cancer immunology …

Inhibition of SARS-CoV-2 by targeting conserved viral RNA structures and sequences

S Hegde, Z Tang, J Zhao, J Wang - Frontiers in Chemistry, 2021 - frontiersin.org
The ongoing COVID-19/Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2)
pandemic has become a significant threat to public health and has hugely impacted …